Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| FEDERAL MOGU | FDML | 7.88% |
| RADIANT LOGI | RLGT | 4.26% |
| SUMMER INFAN | SUMR | 3.92% |
| NATUS MEDICA | BABY | 3.86% |
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
It is a Zacks #2 Rank (Buy) stock.
Company Description
Aptargroup supplies pumps, dispensers, closures, and valves for a variety of markets around the globe. Over half of the company's sales come from Europe.
It is headquartered in Crystal Lake, Illinois and has a market cap of $3.29 billion.
Fourth Quarter Results
Aptargroup reported fourth quarter earnings per share of 59 cents, in-line with the Zacks Consensus Estimate. It was a 14% increase over the same quarter in 2009.
Net sales were up 11% excluding currency effects. The Beauty & Home segment was particularly strong, increasing 13% year-over-year thanks to strong demand from the fragrance/cosmetic market. The Pharma segment was also strong with a 10% increase, while Closures were up 8%.
Gross profit as a percentage of sales declined, however, from 34.1% to 32.2% in the period due to rising input costs. Meanwhile, operating income rose 8%.
Outlook
Aptargroup grew earnings per share by a whopping 39% in 2010 as the global economic recovery gained traction. Don't expect this type of growth in 2011, however.
CEO Peter Pfeiffer noted in the Q4 press release that "while we experienced exceptional growth in 2010, we anticipate that generally our segments will reflect more normalized growth rates going forward. Though several challenges lie ahead, including rising input costs and our ability to pass through such increases in a timely manner, we have faced similar challenges in the past."
Analysts are still expecting double-digit earnings growth over the next two years. The Zacks Consensus Estimate for 2011 is $2.77, representing a 12% increase over 2010 EPS. The 2012 consensus estimate is 10% higher at $3.05.
It is a Zacks #2 Rank (Buy) stock.
Income
Aptargroup has a history of rewarding its shareholders through steady dividend increases. It has raised its dividend at a compound annual rate of 21.8% since over the last 10 years, as seen in the chart below:
It currently yields 1.5%.
Valuation
Shares are trading at 17.7x forward earnings, a premium to the industry average of 13.2x, but still reasonable.
Its price to book ratio of 2.6 is slightly above its peers at 2.4, but also still within reason.
Read the September 14 article here.
This Week's Growth & Income Zacks Rank Buy Stocks:
Qualcomm Incorporated (QCOM) is well positioned to benefit from increased demand for 3G devices such as smartphones, tablets, and eBook readers. It also has a strong financial position with over $19 billion in cash, cash equivalents and marketable securities and no long-term debt. Read the full article.
Republic Bancorp, Inc. (RBCAA) just completed its most successful year in company history, according to CEO Steve Trager. This small cap bank is truly unique in that it has increased its dividend for 11 consecutive years. It currently yields 3.1%. Read the full article.
Raven Industries (RAVN) recently reported strong fourth quarter results in which net sales jumped 27%. Earnings per share also came in 17% ahead of the Zacks Consensus Estimate. Management expects another solid year ahead with "double-digit profit growth". Read the full article.
TELUS Corp (TU) has the trifecta of solid earnings growth, a fat dividend, and attractive valuation. To top it off, analysts have been revising their estimates higher over the last several months as the company continues to outperform expectations. Read the full article.
Todd Bunton is the Growth & Income Stock Strategist for Zacks.com.
Read the full reports :
Snapshot Report on ATR